Restarting anticoagulation may be cost-effective in some VTE cases
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Thromboembolism
Warfarin dosing in HIV patients with deep venous thrombosis
Results showed that mean induction times, analyzed in 170 patients, were 12.87 days in the HIV-infected patients and 11.19 days in the HIV-uninfected patients.
Surgical pulmonary embolectomy for thrombus distribution is feasible, effective
Surgical pulmonary embolectomy for peripheral distribution of thrombus demonstrated positive outcomes in patients with either CPE or PPE.
Short-term oral corticosteroid use associated with increased risk for sepsis, venous thromboembolism
Approximately 1 in 5 American adults use corticosteroids in the short term, which is associated with an increased risk for sepsis, venous thromboembolism, and fracture.
Testosterone treatment may increase risk of venous thromboembolism
Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.
Warfarin may be linked to reduced thromboembolism in nonvalvular atrial fibrillation
The reduction in thromboembolism was attenuated after accounting for competing death events.
In patients with first unprovoked venous thromboembolism, adding CT to limited cancer screening may not lead to statistically higher rate of cancer detection
Unprovoked venous thromboembolism has been associated with the presence of occult malignancies.
Next post in Evidence-Based Medicine
